Efficacy of Photodynamic Diagnosis Is Confined to the Low‐Risk Subgroup of Intermediate‐Risk Non‐Muscle‐Invasive Bladder Cancer: A Propensity Score Matched Analysis
International Journal of Urology · 2026
DOI: 10.1111/iju.70365 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Urology, 2026. Verfasst von Yohei Abe und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Faculty of Medicine, Kagawa University, Kagawa, Japan. Hauptthemen laut MEDLINE: Non-Muscle Invasive Bladder Neoplasms, Neoplasm Recurrence, Local, Urinary Bladder Neoplasms. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Objectives
Intermediate‐risk (IR) non‐muscle‐invasive bladder cancer (NMIBC) is a heterogeneous disease. In this study, we aimed to evaluate the efficacy of photodynamic diagnosis (PDD)‐assisted transurethral resection of the bladder (TURBT) using the recently validated International Bladder Cancer Group (IBCG) risk stratification model for IR‐NMIBC.
Methods
We conducted a single‐center retrospective analysis of 193 patients with IR‐NMIBC who underwent either PDD‐assisted with oral 5‐aminolevulinic acid ( n = 69) or white‐light (WL) TURBT ( n = 126) between 2009 and 2023. We performed 1:1 propensity score matching (PSM) to balance baseline characteristics. Recurrence‐free survival (RFS) was compared between the groups using the Kaplan–Meier method with subgroup analyses based on IBCG risk strata (IR‐low, IR‐intermediate/high).
Results
After PSM, 69 patients with well‐balanced characteristics remained in each group. PDD was associated with a significantly improved RFS compared with WL‐TURBT in the overall cohort ( p = 0.016). Using subgroup analysis, this benefit was most pronounced in the IR‐low risk group ( p = 0.025), whereas no significant difference was found in the IR‐intermediate/high‐risk group ( p = 0.14). Regarding multivariate analysis, PDD was an independent predictor of improved RFS in both the entire IR cohort (hazard ratio [HR]: 0.421, p = 0.009) and IR‐low subgroup (HR: 0.361, p = 0.047).
Conclusions
PDD‐assisted TURBT significantly improved the recurrence outcomes in patients with IR‐NMIBC, with the greatest benefit observed in the IR‐low risk subgroup. These findings support a stratified approach in which PDD is a cornerstone of management of IR‐low patients, while highlighting the need for further research to optimize treatment strategies for IR‐intermediate/high patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
ORCID-Profile: Yohei Abe, Rikiya Taoka, Hirohito Naito, Yoichiro Tohi, Takuma Kato, Mikio Sugimoto
Zitieren
APA
Abe, Y., Taoka, R., Kaji, A., Harada, S., Fujiwara, K., Kohashiguchi, K., Naito, H., Tohi, Y., Kato, T., Okazoe, H., Ueda, N., & Sugimoto, M. (2026). Efficacy of Photodynamic Diagnosis Is Confined to the Low‐Risk Subgroup of Intermediate‐Risk Non‐Muscle‐Invasive Bladder Cancer: A Propensity Score Matched Analysis. International Journal of Urology. https://doi.org/10.1111/iju.70365
Vancouver
Abe Y, Taoka R, Kaji A, Harada S, Fujiwara K, Kohashiguchi K, et al. Efficacy of Photodynamic Diagnosis Is Confined to the Low‐Risk Subgroup of Intermediate‐Risk Non‐Muscle‐Invasive Bladder Cancer: A Propensity Score Matched Analysis. International Journal of Urology. 2026. doi:10.1111/iju.70365
BibTeX
@article{Abe2026,
author = {Abe, Yohei and Taoka, Rikiya and Kaji, Asuka and Harada, Satoshi and Fujiwara, Kengo and Kohashiguchi, Kana and Naito, Hirohito and Tohi, Yoichiro and Kato, Takuma and Okazoe, Homare and Ueda, Nobufumi and Sugimoto, Mikio},
title = {Efficacy of Photodynamic Diagnosis Is Confined to the Low‐Risk Subgroup of Intermediate‐Risk Non‐Muscle‐Invasive Bladder Cancer: A Propensity Score Matched Analysis},
journal = {International Journal of Urology},
year = {2026},
doi = {10.1111/iju.70365}
}
EUVIMED